Peptide-based immunotherapeutic approaches to glioma: a review (Q36810278)

16 August 2017

1 reference

title

Peptide-based immunotherapeutic approaches to glioma: a review (English)

1 reference

16 August 2017

1 reference

Ryuya Yamanaka

1

1 reference

PubMed ID

17477802

16 August 2017

Kyogo Itoh

series ordinal

2

1 reference

PubMed ID

17477802

16 August 2017

language of work or name

English

0 references

publication date

1 May 2007

1 reference

Expert Opinion on Biological Therapy

16 August 2017

1 reference

16 August 2017

7

1 reference

16 August 2017

5

1 reference

16 August 2017

645-649

1 reference

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

16 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Production of IL-10 by melanoma cells: examination of its role in immunosuppression mediated by melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Immunological monitoring during combination of patient-oriented peptide vaccination and estramustine phosphate in patients with metastatic hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Cell lineage and cell migration in the neural crest

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Tumor antigens in astrocytic gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Identification of a human glioma antigen, SOX6, recognized by patients' sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

EphA2 as a glioma-associated antigen: a novel target for glioma vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

AIM-2: a novel tumor antigen is expressed and presented by human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Expression of the tumor-rejection antigen SART1 in brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Personalized peptide vaccines: a new therapeutic modality for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.5.645

21 January 2018

Identifiers

DOI

10.1517/14712598.7.5.645

1 reference

16 August 2017

1 reference

PubMed ID

17477802